About us

The Institute of Molecular Genetics (IGM) was founded in September 2000 by the fusion of two CNR centers in Pavia: the Institute of Biochemical and Evolutionary Genetics (IGBE) and the Centre for Histochemical Studies (CSI). In 2007, a further section in Bologna, previously part of another CNR Institute (ITOI: Institute for Organ Transplantation and Immunology), joined IGM. Thanks to a formal collaboration agreement, the section in Bologna is hosted within the Orthopedic Rizzoli Institute. 

In spite of this complex history, the various components of the Institute share common scientific interests with a high level of methodological complementarity. IGM combines investigations on basic cellular processes, renowned at international level, with applied and translational research.

IGM is mainly involved in basic research on fundamental biological processes. Four main lines of investigation can be identified, on which converge the activities of groups in Pavia e Bologna:  >>>


Research activities

IGM researches on basic biological mechanisms is completed with a likewise qualified translational research. Three main research fields can be identified: 1) molecular analysis of hereditary genetic diseases, 2) molecular characterzation of acquired genetic diseases such as tumors and their prograssion to metastasis, 3) development of techniques and screening of new compounds. Research activities of the various groups are strictly interrelated utilizing the front-line methods of the modern biology (biochemical and pharmacological approach, molecular genetics and biology, cellular biology and bio-computing).  >>>



National Research Council of Italy




                   DSB - CNR                       Transparent Administration            





                                 Imaging @ IGM         







seminari ma non solo!       Network Italiano Laminopatie              CABGen



CNR - Department of Biological Sciences   




Abnormal Metabolic states, cellular stressors and NeuroDegenerative processes

Basic methodologies for innovation in the diagnosis and treatment of multifactorial diseases




           Italian Foundation for Cancer Research

                    Molecular Oncology Institute



Adriano Buzzati-Traverso





On May 31st, 2018 at 14:30 at IGM Seminar Room "A. Falaschi", Prof. Riccardo Brambilla (Cardiff University) will hold the following seminar: "Towards new therapeutics for cognitive deficits associated to...


On May 29th, 2018 at 14:30, at IGM Seminar Room "A. Falaschi",  Dr. Silvia Garavaglia (Universita' del Piemonte Orientale) will hold the following seminar: "Targeting aldheyde dehydrogenase 1A3 in gliomas:...


On Aprile 10th, 2018 at 15:00, at IGM Seminar Room "A. Falaschi",  Dr. Lucia Mancino (Chief Scientific Officer, Fondazione Telethon) will hold the following seminar: "Translating the results of basic...

Non-coding RNA: the DNA damage fingerprints of cancer cells

The integrity of our genome has to be maintained ed to prevent accumulation of harmful mutations, or cell death. This is even more needed in tumor cells where breaks in DNA occur at higher frequency. This feature of cancer cells...

Displaying results 1 to 4 out of 94








Next >

Copyright © 2014 Home_en